Who Paid My Doc
Amer Samdani
Neurological Surgery Philadelphia, PA Medical Doctor
NPI 1760461537 CMS profile 170269
3551 N Broad St, Philadelphia, PA 19140
General payments
$4,410,584
Research payments
$145,291
Ownership & investment interest
$92,295
Research they led as principal investigator
$281,282
Through program year 2025, Amer Samdani of Philadelphia, PA is reported in the CMS Open Payments database as having received $4,410,584 across 1,202 general payments and $145,291 in research payments paid to them. Separately, studies naming them as principal investigator received $281,282 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $92,295 across 1 holding.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
12 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $820,757 | 167 | |
| 2024 | General | $622,263 | 139 | |
| 2023 | General | $750,212 | 185 | |
| 2023 | Research | $29,273 | 3 | |
| 2022 | General | $1,078,930 | 192 | |
| 2021 | General | $250,676 | 168 | |
| 2021 | Research | $31,145 | 4 | |
| 2020 | General | $492,614 | 149 | |
| 2020 | Research | $20,046 | 4 | |
| 2019 | General | $395,131 | 202 | |
| 2019 | Research | $64,827 | 13 | |
| 2023 | Ownership | $92,295 | 1 |
Beside peers
- Amer Samdani
- Neurological Surgery median
- Middle half of Neurological Surgery
- National median
In program year 2025, general payments to Amer Samdani were reported at $820,757. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.
Show as a table
| Year | Amer Samdani | Neurological Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $395,131 | $582 | $138–$3,006 | $163 |
| 2020 | $492,614 | $294 | $76–$2,174 | $114 |
| 2021 | $250,676 | $387 | $105–$2,432 | $132 |
| 2022 | $1,078,930 | $542 | $139–$2,989 | $149 |
| 2023 | $750,212 | $534 | $145–$2,697 | $160 |
| 2024 | $622,263 | $574 | $155–$3,046 | $164 |
| 2025 | $820,757 | $596 | $159–$3,102 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
1,226 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurological Surgery in Pennsylvania
Steven Falowski
Neurological Surgery · Fountain Hill, PA
Adam Kanter
Neurological Surgery · Pittsburgh, PA
David Okonkwo
Neurological Surgery · Pittsburgh, PA
Brian Jankowitz
Neurological Surgery · Philadelphia, PA
Gaurav Jain
Neurological Surgery · Wynnewood, PA
Joshua Heller
Neurological Surgery · Philadelphia, PA
Related records
Neurological Surgery in Pennsylvania
Practitioners in the same specialty and state, ranked by reported value.
All Neurological Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Pennsylvania
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.